Percheron Therapeutics Limited

Percheron Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The products are in-licensed from Ionis Pharmaceuticals Inc. (NASDAQ: IONS), an established leader in antisense drug development. Their commitment is to provide shareholders, potential investors, and the public…More with a transparent view of their efforts toward fulfilling their purpose: Breakthroughs that change patients’ lives. To that end, their annual reports detail the strategic development, operations, and financial condition of their business. Percheron Therapeutics vision and mission is to bring life changing innovative medicines to patients in need and to add value for all stakeholders through actively exercising their beliefs of honesty, integrity and collaboration. They serve the needs of their patients and stakeholders to the best of their combined abilities.